Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc. News
Prestige Consumer Healthcare Inc. Quantitative Score
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Prestige Consumer Healthcare Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Prestige Consumer Healthcare Inc. Financials
Table Compare
Compare PBH metrics with: | |||
|---|---|---|---|
Earnings & Growth | PBH | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | PBH | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | PBH | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | PBH | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Prestige Consumer Healthcare Inc. Income
Prestige Consumer Healthcare Inc. Balance Sheet
Prestige Consumer Healthcare Inc. Cash Flow
Prestige Consumer Healthcare Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Buy |
| Return on Equity | Buy |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Neutral |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Neutral |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Prestige Consumer Healthcare Inc. Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 0.7875 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2018-10-15 | 0.475 | Quarterly |
| TBA | 0.3125 | Quarterly |
Historical Market Cap
Shares Outstanding
Prestige Consumer Healthcare Inc. Executives
| Name | Role |
|---|---|
| Ronald Lombardi | Chairman, President & Chief Executive Officer |
| Christine Sacco | Chief Financial Officer & Chief Operating Officer |
| Adel Mekhail | Executive Vice President of Marketing & Sales |
| William C. P'Pool | Senior Vice President, General Counsel & Corporate Secretary |
| Jeffrey Zerillo | Senior Vice President of Operations |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Ronald Lombardi | Chairman, President & Chief Executive Officer | Male | 1964 | 2.19M |
| Christine Sacco | Chief Financial Officer & Chief Operating Officer | Female | 1976 | 1.27M |
| Adel Mekhail | Executive Vice President of Marketing & Sales | Male | 1961 | 861.56K |
| William C. P'Pool | Senior Vice President, General Counsel & Corporate Secretary | Male | 1965 | 860.44K |
| Jeffrey Zerillo | Senior Vice President of Operations | Male | 1961 | 531.27K |
Prestige Consumer Healthcare Inc. Insider Trades
| Date | 28 Nov |
| Name | Zerillo Jeffrey |
| Role | Senior VP Operations |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 719 |
| Date | 1 Dec |
| Name | Zerillo Jeffrey |
| Role | Senior VP Operations |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 281 |
| Date | 25 Nov |
| Name | BYOM JOHN E |
| Role | Director |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 3000 |
| Date | 5 Aug |
| Name | Kelly John F. |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 2094 |
| Date | 5 Aug |
| Name | ZIER DAWN M. |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 2094 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 28 Nov | Zerillo Jeffrey | Senior VP Operations | Disposed | S-Sale | 719 |
| 1 Dec | Zerillo Jeffrey | Senior VP Operations | Disposed | S-Sale | 281 |
| 25 Nov | BYOM JOHN E | Director | Disposed | S-Sale | 3000 |
| 5 Aug | Kelly John F. | Director | Acquired | A-Award | 2094 |
| 5 Aug | ZIER DAWN M. | Director | Acquired | A-Award | 2094 |